These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5168500)

  • 1. [Effects of pluronic F-68 on prevention of hemolysis during extracorporeal circulation].
    Onishi K; Kumashiro H; Ueda S; Yakabe J
    Kyobu Geka; 1971 Dec; 24(12):873-7. PubMed ID: 5168500
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of destruction of the blood components during extracorporeal circulation, with particular reference to the use of vitamin E and the Pluronic F-68].
    Tamiya T; Koriyama H; Ito C; Horibe H; Sasaki N
    Kyobu Geka; 1970 Apr; 23(4):275-82. PubMed ID: 5465104
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental study on perfusion-ventilation of the lung--combined use of adrenal cortiocosteroids and pluronic-F 68 for the prevention of postperfusion lung syndrome].
    Kubota H; Homma J; Ozawa T; Tamura M; Sawaguchi R
    Kokyu To Junkan; 1972 Feb; 20(2):159-63. PubMed ID: 4676831
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug influence on platelet loss during extracorporeal circulation.
    Mielke CH; de Leval M; Hill JD; Macur MF; Gerbode F
    J Thorac Cardiovasc Surg; 1973 Dec; 66(6):845-54. PubMed ID: 4759692
    [No Abstract]   [Full Text] [Related]  

  • 5. Poloxalkol R (pluronic F-68): a priming solution for cardiopulmonary bypass.
    Vasko KA; Riley AM; DeWall RA
    Trans Am Soc Artif Intern Organs; 1972; 18(0):526-31, 545. PubMed ID: 4679908
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of Pluronic F-68 to diminish fat emboli and hemolysis during cardiopulmonary bypass. A controlled clinical study.
    Danielson GK; Dubilier LD; Bryant LR
    J Thorac Cardiovasc Surg; 1970 Feb; 59(2):178-84. PubMed ID: 4910815
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial effect of pluronic F-68 on the microcirculation in experimental hemorrhagic shock.
    Grover FL; Newman MM; Paton BC
    Surg Forum; 1970; 21():30-2. PubMed ID: 5514910
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemolysis by nonionic surface-active agents.
    Kondo T; Tomizawa M
    J Pharm Sci; 1968 Jul; 57(7):1246-8. PubMed ID: 5662074
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Pluronic F 68, poloralkol, on vascular resistance in vivo.
    Hoie J; Schenk WG
    J Surg Res; 1971 Oct; 11(10):515-7. PubMed ID: 5111059
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of a polyol in the prevention of hemolysis due to an antifoam agent in pump oxygenators.
    Wells R; Bygdeman S; Sharhriari AA; Matloff JM; Harken DE
    Circulation; 1968 Apr; 37(4 Suppl):II168-72. PubMed ID: 5646576
    [No Abstract]   [Full Text] [Related]  

  • 11. Red blood cell survival after prolonged perfusion with a blood pump.
    Kusserow BK; Clapp JF
    Trans Am Soc Artif Intern Organs; 1966; 12():121-3. PubMed ID: 5960690
    [No Abstract]   [Full Text] [Related]  

  • 12. Contribution to the in vitro testing of pumps for extracorporeal circulation.
    Koller T; Hawrylenko A
    J Thorac Cardiovasc Surg; 1967 Jul; 54(1):22-9. PubMed ID: 6027856
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effects of administration of haptoglobin for hemolysis by extracorporeal circulation].
    Kanamori Y; Tanabe H; Shimono T; Tani K; Yada I; Yuasa H; Kusagawa M
    Rinsho Kyobu Geka; 1989 Oct; 9(5):463-7. PubMed ID: 9301957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acutely traumatized canine ureter. Effects of low molecular weight dextran and surfactant pluronic F-68.
    Block NL; Morales P; Fazzini EP
    Urology; 1974 Feb; 3(2):190-4. PubMed ID: 4812663
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protective effect of vitamin E in hemolysis induced by extracorporeal circulation].
    Aresu G; Binaghi G; Martelli V
    Ann Ital Chir; 1970; 46(4):455-65. PubMed ID: 5526236
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemolytic episodes in extracorporeal circulation].
    Neef H; Panzner R
    Thoraxchir Vask Chir; 1969 Apr; 17(2):167-72. PubMed ID: 5275044
    [No Abstract]   [Full Text] [Related]  

  • 17. [Extracorporeal circulation with hemodilution--with special reference to hemolysis and peripheral circulation].
    Ueda S
    Igaku Kenkyu; 1975 Jan; 45(1):45-62. PubMed ID: 1239900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fructose-1,6-diphosphate administration during extracorporeal circulation. I. Reduction of post-perfusion hemolysis].
    Barberis L; Brisighella A; Lijoi A; Pansini S; Scarano F; Scoti P; Passerone GC; De Gaetano G; Petillo A; Venere G
    Minerva Cardioangiol; 1983 Apr; 31(4):187-9. PubMed ID: 6877618
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of an industrial surfactant (pluronic F-68) on human amniotic fluid embolism.
    Hymes AC; Robb HJ; Margulis RR
    Am J Obstet Gynecol; 1970 Aug; 107(8):1217-22. PubMed ID: 5466410
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hemolyzing properties of the pericardium, epicardium and pleura during operations on the heart under extracorporeal circulation].
    Zin'kovskiĭ MF
    Grudn Khir; 1966; 8(3):37-40. PubMed ID: 5981521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.